SN-ISCO join hands to treat corneal blindness

Chennai-based Sankara Nethralaya and California-based biotechnology firm International Stem Cell Corporation (ISCO) have formed a collaboration to develop ISCO’s “CytoCor” stem cell-derived corneal tissue. The goal is to use CytoCor to treat corneal blindness and vision impairment.

Read more..

Tags: , ,
Previous Post

First batch of medical secretaries complete training at TSNA

Next Post

2010 Alumni meet

Leave a Reply

Your email address will not be published. Required fields are marked *